AAMI TIR16-2023 PDF
Name in English:
St AAMI TIR16-2023
Name in Russian:
Ст AAMI TIR16-2023
Original standard AAMI TIR16-2023 in PDF full version. Additional info + preview on request
Full title and description
AAMI TIR16:2023 — Microbiological aspects of ethylene oxide sterilization. This Technical Information Report provides guidance on microbiological considerations for the development, validation and routine control of ethylene oxide (EO) sterilization processes for medical devices, supplementing ANSI/AAMI/ISO 11135:2014 and related documents.
Abstract
AAMI TIR16:2023 addresses the microbiological aspects of designing and validating EO sterilization processes. It offers practical guidance on selection and use of biological indicators, process definition and performance qualification approaches (including overkill and BI/bioburden methods), use of process challenge devices (PCDs) for routine processing, and considerations for contract sterilization and parametric release where applicable.
General information
- Status: Current (AAMI TIR16:2023).
- Publication date: 18 December 2023 (2023 edition).
- Publisher: Association for the Advancement of Medical Instrumentation (AAMI).
- ICS / categories: 11.080.01 (Sterilization and disinfection in general).
- Edition / version: AAMI TIR16:2023 (revises AAMI TIR16:2017 (R2020)).
- Number of pages: 52 pages (ISBN record available).
Scope
The TIR provides additional microbiological guidance to augment ANSI/AAMI/ISO 11135:2014 for medical device manufacturers and organizations that use contract sterilization. It focuses on microbiological test methods, biological indicator selection and interpretation, validation strategies (including alternatives to classic half‑cycle overkill), routine process control using BIs and PCDs, and considerations for process characterization and product release. It explicitly does not attempt to cover every factor that can affect product bioburden upstream of sterilization.
Key topics and requirements
- Guidance on biological indicators (BI): selection, placement, interpretation and use for release decisions.
- Recommendations for Process Challenge Devices (PCDs) in routine processing when BI-based release is used.
- Validation approaches: overkill (half‑cycle) rationale, overkill cycle calculation, and BI/bioburden approaches to validation and routine control.
- Process definition and performance qualification — characterization of exposure, humidity, EO concentration and chamber conditions that affect lethality.
- Considerations for contract sterilization operations, including responsibilities between device manufacturer and contract sterilizer.
- Discussion of parametric release and use of ISO 11138‑7 where applicable.
- Practical recommendations to align microbiological practice with ISO 11135 and related microbiological standards.
Typical use and users
Primary users are sterility assurance and microbiology professionals in medical device manufacturing, contract sterilization providers, regulatory and quality personnel, and consultants involved in EO process development, validation, and routine control. The TIR is used to design validation protocols, specify BI/PCD strategies, prepare submission documentation, and develop routine monitoring and release procedures.
Related standards
Closely related documents include ANSI/AAMI/ISO 11135 (Ethylene oxide — requirements for development, validation and routine control), ISO 11737‑1 and ISO 11737‑2 (microbiological methods for bioburden and sterility testing), ISO 11138 series (biological indicators), ISO 11140 (chemical indicators), ISO 13485 (quality management for medical devices), and other AAMI TIRs addressing EO physical aspects and sterilization practice.
Keywords
ethylene oxide; EO sterilization; microbiological validation; biological indicator (BI); process challenge device (PCD); overkill; bioburden; parametric release; sterility assurance; ISO 11135.
FAQ
Q: What is this standard?
A: AAMI TIR16:2023 is a Technical Information Report providing microbiological guidance for the development, validation and routine control of ethylene oxide sterilization processes for medical devices.
Q: What does it cover?
A: It covers microbiological test methods and strategies (BIs, PCDs), validation approaches (overkill and BI/bioburden methods), process definition and qualification topics, and practical considerations for manufacturers and contract sterilizers. It supplements, but does not replace, the requirements of ISO 11135 and related standards.
Q: Who typically uses it?
A: Sterility assurance and microbiology professionals at device manufacturers, contract sterilization facilities, quality/regulatory teams, and consultants involved in EO sterilization validation and routine control.
Q: Is it current or superseded?
A: The 2023 edition (AAMI TIR16:2023) is the current edition, published in December 2023; it revises and replaces AAMI TIR16:2017 (R2020).
Q: Is it part of a series?
A: Yes — it is one of several AAMI Technical Information Reports and guidance documents related to sterilization (for example AAMI TIR15 on physical aspects of EO sterilization) and is intended to be used alongside ISO 11135 and the ISO 11138/11737 series.
Q: What are the key keywords?
A: Ethylene oxide, EO sterilization, biological indicator, process challenge device, bioburden, validation, sterility assurance, parametric release, ISO 11135.